Last update 08 May 2025

TT-9701

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
Chk1
Action
inhibitors
Mechanism
Chk1 inhibitors(Checkpoint kinase 1 inhibitors)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Refractory acute myeloid leukemiaRelapsing acute myeloid leukemia
Inactive Indication-
Originator Organization-
Active Organization
Zhongshan Institute for Drug DiscoveryShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of SciYan Tai Xin Yao Chuang Zhi Shan Dong Sheng Shi Yan Shi
+ [1]
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with TT-9701
Login to view more data
100 Translational Medicine associated with TT-9701
Login to view more data
100 Patents (Medical) associated with TT-9701
Login to view more data
100 Deals associated with TT-9701
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaIND Approval
China
Yan Tai Xin Yao Chuang Zhi Shan Dong Sheng Shi Yan Shi
07 Apr 2025
Refractory acute myeloid leukemiaIND Approval
China
Zhongshan Institute for Drug Discovery
07 Apr 2025
Refractory acute myeloid leukemiaIND Approval
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
07 Apr 2025
Refractory acute myeloid leukemiaIND Approval
China
Zhejiang UniversityZhejiang University
07 Apr 2025
Relapsing acute myeloid leukemiaIND Approval
China
Yan Tai Xin Yao Chuang Zhi Shan Dong Sheng Shi Yan Shi
07 Apr 2025
Relapsing acute myeloid leukemiaIND Approval
China
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
07 Apr 2025
Relapsing acute myeloid leukemiaIND Approval
China
Zhongshan Institute for Drug Discovery
07 Apr 2025
Relapsing acute myeloid leukemiaIND Approval
China
Zhejiang UniversityZhejiang University
07 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free